Immunovia reports promising results for next-gen pancreatic cancer diagnostic
December 09, 2024
Immunovia announces the completion of a promising study to detect early-stage pancreatic ductal adenocarcinoma. Rosalie Sears, M.D., says, “This study validates the high accuracy of the Immunovia test in detecting stage 1 and 2 pancreatic cancer in a challenging high-risk population.”